In 2022, more than eight in every ten women of reproductive age in the U.S. used some contraceptive method in the past year. White women capable of becoming pregnant reported the highest contraceptive use, with 87 percent. This statistic illustrates the percentage of reproductive-aged women in the U.S. that reported using contraception in the past year as of 2022, by race and ethnicity.

United States US: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data was reported at 63.100 % in 2014. This records a decrease from the previous number of 70.100 % for 2012. United States US: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data is updated yearly, averaging 68.100 % from Dec 1965 (Median) to 2014, with 15 observations. The data reached an all-time high of 73.200 % in 1975 and a record low of 49.100 % in 1965. United States US: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Health Statistics. Contraceptive prevalence rate is the percentage of women who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. It is usually measured for women ages 15-49 who are married or in union. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.; ; Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.; Weighted average;

Forecast: Contraceptive Prevalence in the US 2022 - 2026 Discover more data with ReportLinker!

United States US: Unmet Need for Contraception: % of Married Women Aged 15-49 data was reported at 9.000 % in 2014. This records an increase from the previous number of 8.000 % for 2010. United States US: Unmet Need for Contraception: % of Married Women Aged 15-49 data is updated yearly, averaging 6.000 % from Dec 1988 (Median) to 2014, with 7 observations. The data reached an all-time high of 9.000 % in 2014 and a record low of 4.000 % in 1988. United States US: Unmet Need for Contraception: % of Married Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Unmet need for contraception is the percentage of fertile, married women of reproductive age who do not want to become pregnant and are not using contraception.; ; Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.; Weighted Average; Unmet need for contraception measures the capacity women have in achieving their desired family size and birth spacing. Many couples in developing countries want to limit or postpone childbearing but are not using effective contraception. These couples have an unmet need for contraception. Common reasons are lack of knowledge about contraceptive methods and concerns about possible side effects.

A survey from 2022 found that around 22 percent of U.S. adults used wearable contraceptive devices such as condoms in the past month to prevent pregnancy. This statistic shows the percentage of U.S. adults who used select contraceptive methods to prevent pregnancy in the last month as of 2022.

The size of the Contraceptive Industry in U.S. market was valued at USD 5.12 Million in 2023 and is projected to reach USD 7.66 Million by 2032, with an expected CAGR of 5.93% during the forecast period.The US contraceptive industry has been transformed for decades due to a response to changes in healthcare, changing social norms, and growing knowledge about family planning and sexual health. The market is vast and may encompass items such as: hormonal contraceptives such as pills, patches, and injections; barrier methods in the form of condoms and diaphragms; intrauterine devices (IUDs); and emergency contraception. The prescription-based products, especially oral contraceptives and intrauterine devices, make the largest segment of the market. Due to the wide availability of over-the-counter varieties, such as condoms and emergency contraceptives, they also fall under this category.Among the factors that contributed to the rapid growth of the contraceptive market in the U.S. include government programs about reproductive health, increased access to care through Affordable Care Act provisions, and the rising knowledge base about STIs. Long-acting reversible contraceptives, including IUDs and implants, also have high rates of success and are easy to apply and remove, making them in strong demand.Cultural and religious opposing views and probable high costs of some products will be constraining the growth of the market. Increased legal and political debate surrounding the reproduction rights, like access to contraception and abortion services, would further complicate the direction of the future of the industry Key drivers for this market are: Rise in Government Initiatives and Increasing Awareness about Sexually Transmitted Diseases (STDs), Rising Rate of Unintended Pregnancies. Potential restraints include: Side Effects Associated with the Use of Contraceptive Devices. Notable trends are: Condoms are Expected to Dominate the USA Contraceptive Devices Market.

In 2022, mood changes and weight gain were the most common side effects from contraception experienced by women in the U.S. in the past year, as reported by almost half of respondents. In addition, nearly eight out of ten women who used contraception said they had experienced two or more side effects. This statistic illustrates the percentage of contraceptive-using women in the U.S. who experienced select side effects from contraception that were unexpected or more severe than expected as of 2022.

The contraceptive industry in the United States is estimated to be worth XX million in 2025 and is projected to grow at a CAGR of 5.90% from 2025 to 2033. The growth of the market is attributed to factors such as increasing awareness about family planning, rising prevalence of sexually transmitted diseases (STDs), and government initiatives to promote reproductive health. The market is segmented based on product type (drugs and devices), gender (male and female), and geography (North America, Europe, and Asia-Pacific). Some of the key market players include Church & Dwight Co Inc, Bayer AG, Teva Pharmaceuticals Ltd, Merck & Co Inc, and Johnson & Johnson Ltd. The major drivers of the contraceptive industry in the United States include the increasing demand for effective and convenient contraceptive methods, rising awareness about reproductive health, and government initiatives to promote family planning. However, the market also faces certain restraints, such as the high cost of some contraceptive methods, religious and cultural factors, and side effects associated with certain contraceptive drugs and devices. In terms of trends, the market is witnessing the emergence of new contraceptive technologies, such as long-acting reversible contraceptives (LARCs), and the growing popularity of online platforms for contraceptive sales. Key drivers for this market are: , Increasing Rate of Unintended Pregnancies; Rise in Government Initiatives. Potential restraints include: , Side Effects Associated with the Use of Contraceptive Drugs and Devices. Notable trends are: Condoms are Expected to Dominate the Contraceptive Devices Market.

In 1991, the birth rate for girls aged 10 to 14 years in the United States stood at 1.4 births per every thousand girls. Since 1991, this rate has consistently decreased, dropping to .2 in the year 2023. This statistic depicts the number of births per thousand U.S. females aged 10 to 14 years between 1991 and 2023. Teenage pregnancy and contraception Over the years, the rate of teenage pregnancy and birth has declined in the United States, most likely due to lower rates of sexual activity in this age group as well as increased use of birth control methods. However, the use and accessibility of contraceptives remains a problem in many parts of the United States. For example, in 2021, only 21 percent of sexually active high school students reported using the birth control pill to prevent pregnancy before their last sexual intercourse. This rate was highest among white high students and lowest among Black students, with only 11 percent reporting use of the birth control pill before their last intercourse. Condom use is more prevalent among high school students than use of the pill, but still only just over half of high school students reported using a condom the last time they had sex as of 2021. Disparities in teenage pregnancy Although rates have decreased over the past decades, teenage pregnancy and birth rates in the U.S. are still higher than in other Western countries. Geographic, racial, and ethnic disparities in teen birth rates are still prevalent within the country. In 2023, teenage birth rates were highest among Native Hawaiian and Pacific Islanders. Other contributing factors to high teen birth rates also include poor socioeconomic conditions, low education, and low-income status.

In 2022, more than eight in every ten women of reproductive age in the U.S. used some contraceptive method in the past year. White women capable of becoming pregnant reported the highest contraceptive use, with 87 percent. This statistic illustrates the percentage of reproductive-aged women in the U.S. that reported using contraception in the past year as of 2022, by race and ethnicity.

A survey from December 2020 found that around eight percent of women aged 18 to 25 years either delayed or could not get birth control during the COVID-19 pandemic. This statistic shows the percentage of women who had delayed or not been able to get birth control because of the COVID-19 pandemic as of December 2020, by age group.

A survey of college students in the United States from the fall of 2024 found that the most common method of birth control among college students is the male condom, followed by birth control pills, and the withdrawal method. At that time, about 55 percent of college students in the U.S. reported they used a male condom to prevent pregnancy the last time they had vaginal intercourse, while 40 percent used birth control pills. Contraception among women in the United States Similarly to college students, male condoms and oral contraceptives are the most common forms of contraception among all adult women in the United States. As of 2024, around 25 percent of women of reproductive age in the United States had used male condoms in the past year, while 22 percent had used oral contraceptives. These forms of contraception are more common among women aged 18 to 25 years, while the intrauterine device (IUD) is more common among women aged 26 to 35 years than any other age group. The number one reason U.S. women use contraception is to avoid pregnancy. Condom use among high school students In 2023, around 52 percent of high school students in the United States reported using a condom during their last sexual intercourse. The share of U.S. high school students who reported using a condom during their last sexual intercourse has deceased over the last decade, with around 59 percent reporting condom use in 2013. In 2023, Hispanic high school students were the most likely to have used a condom the last time they had sex, while Asian students were least likely to have used a condom. However, every race/ethnicity saw decreases in condom use from 2013 to 2023.

A survey from 2022 found that around 22 percent of U.S. adults used wearable contraceptive devices such as condoms in the past month to prevent pregnancy. This statistic shows the percentage of U.S. adults who used select contraceptive methods to prevent pregnancy in the last month as of 2022.

This data package includes data about nonmarital childbearing, estimation of morbidity levels related to mother and child shared by the Big Cities Health Coalition members, infant, neonatal, postneonatal, fetal, late fetal and perinatal mortality rates, information over the Pregnancy Risk Assessment Monitoring System (PRAMS), low birth weight and very low birth weight and Breastfeeding among mothers aged between 15 and 44.

美国：避孕普及率：现代方法：占15-49岁女性百分比在12-01-2014达63.100%，相较于12-01-2012的70.100%有所下降。美国：避孕普及率：现代方法：占15-49岁女性百分比数据按年更新，12-01-1965至12-01-2014期间平均值为68.100%，共15份观测结果。该数据的历史最高值出现于12-01-1975，达73.200%，而历史最低值则出现于12-01-1965，为49.100%。CEIC提供的美国：避孕普及率：现代方法：占15-49岁女性百分比数据处于定期更新的状态，数据来源于World Bank，数据归类于全球数据库的美国 – 表 US.世行.WDI：卫生统计。

In 2022-2023, there were around 2.25 million contraceptive services provided by Planned Parenthood affiliate health centers in the United States. This statistic illustrates the number of services provided by Planned Parenthood affiliate health centers in the United States for the year ending June 30, 2023, by category.

The global female contraception market, valued at approximately $XX million in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 8.50% from 2025 to 2033. This expansion is fueled by several key drivers. Increased awareness of family planning and reproductive health, particularly among women in developing nations, is a significant factor. Furthermore, government initiatives promoting access to contraceptives and sexual education are contributing to market growth. The rising prevalence of sexually transmitted infections (STIs) and the desire to prevent unintended pregnancies are also stimulating demand for various contraceptive methods. Technological advancements, such as the development of more effective and user-friendly contraceptive devices and drugs, further contribute to market expansion. Market segmentation reveals a diverse landscape, with oral contraceptives, contraceptive injections, and intrauterine devices (IUDs) holding significant market shares. The market also witnesses strong competition amongst key players like Bayer AG, Pfizer Inc., and Johnson & Johnson, driving innovation and the introduction of new products. However, the market faces certain restraints. Cultural and religious beliefs in some regions continue to limit access to and usage of contraceptives. Concerns about potential side effects associated with hormonal contraceptives also influence consumer choices. Furthermore, variations in healthcare infrastructure and access across different geographical regions impact market penetration. Despite these challenges, the long-term outlook remains positive, driven by ongoing advancements in contraceptive technology, increased female empowerment, and sustained government support for family planning programs. The regional distribution of the market shows strong performances in North America and Europe, attributed to higher levels of awareness, access to healthcare, and disposable income. However, Asia-Pacific and other developing regions present significant growth opportunities due to expanding populations and increasing demand for family planning solutions. Recent developments include: In November 2022, Lupin received approval from the US FDA for its abbreviated new drug application (ANDA), Drospirenone Tablets in 4 mg, used to prevent pregnancy, in the United States., In July 2022, Organon entered into a research collaboration and exclusive license agreement with Denmark's Cirqle Biomedical for a novel investigational non-hormonal, on-demand contraceptive candidate.. Key drivers for this market are: Increasing Incidence of the Sexually Transmitted Diseases (STDs), Increasing Rate of Unintended Pregnancies; Rise in Government Initiatives. Potential restraints include: Increasing Incidence of the Sexually Transmitted Diseases (STDs), Increasing Rate of Unintended Pregnancies; Rise in Government Initiatives. Notable trends are: Sub-dermal Contraceptive Implants Segment is Expected to Register a Healthy Growth Over the Forecast Period.

Africa Unmet Need for Contraception Dataset

  Dataset Summary

Annual share of women with unmet need for contraception among married women ages 15–49 for African countries. Data are provided as percentages. Cleaned and reformatted for ML pipelines with Africa-only subsets in long and pivot formats.

Indicator: World Bank — Unmet need for contraception (% of married women ages 15–49) (SP.UWT.TFRT) Geographic scope: 54 African countries (ISO‑3 list consistent across this repo)… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/Unmet-need-for-contraception-Percentage-of-married-women-ages-15-49.

A volatile regulatory environment at the state and federal levels has altered the makeup and concentration of some of the many family planning services clinics offer. In addition, declining patient volume because of telehealth expansion and an uncertain future regarding government funding has led to some clinics closing and to the concentration of services in some locations or drought in others. In particular, pregnancy termination services remain concentrated in independent clinics, and with medication abortion restrictions, these independent clinics will face an increase in demand. As medication abortions represent 63.0% of U.S. cases, telehealth restrictions in 28 states (Guttmacher 2025) still restrict access to medication abortion. Despite the significant shifts in pregnancy termination services, Medicaid is available for other planning services (in-person and telemedicine) and industry revenue is expected to climb at a CAGR of 3.5% by 2025 and reach $4.7 billion, when revenue will climb by 3.2% in 2025 alone. Technology continues to impact the clinic. Virtual-only clinics are increasingly providing telehealth services. Mobile abortion clinics aim to reduce travel for women in states with legal but distant abortion access and to bring family planning to others where there is a lack of maternal healthcare. Positioned near state borders where abortion is banned, they minimize driving time. Planned Parenthood, one of the largest providers of family planning services, operates mobile clinics, bringing services to states with service restrictions and to markets with shortages or undersupply of services. State actions may continue to counter federal bans that restrict services and shift in entry. For example, the Arizona Abortion Access Act may alter a clinic's decision to open a facility in the state. However, in April 2025, the federal government withheld Title X funding from 16 organizations, impacting clinics' budgets and services, including organizations like Planned Parenthood. Continued legal actions, state funding and advocacy efforts will continue to address and reverse these freezes. Looking forward, per capita disposable income will support donations and philanthropy. Assuming compensatory services are provided in other locations to offset state regulatory actions and with moderate growth in Medicaid funding, industry revenue will climb at an annual rate of 2.8% through 2030, reaching $5.4 billion, while profit remains stable.

This statistic displays the percentage of U.S. men that used select contraceptive methods during their last sexual intercourse within the last 3 months from 2002 to 2015. In 2002, around *** percent of men used the withdrawal method to avoid pregnancy. Comparatively, **** percent of men had used this technique from 2011-2015.